B of A Securities Downgrades Medical Properties Trust to Neutral, Announces $21.5 Price Target
B of A Securities analyst Joshua Dennerlein downgrades Medical Properties Trust (NYSE:MPW) from Buy to Neutral and announces $21.5 price target.
Goldman Sachs Downgrades Limelight Networks to Sell, Lowers Price Target to $2.5
Goldman Sachs analyst Brett Feldman downgrades Limelight Networks (NASDAQ:LLNW) from Neutral to Sell and lowers the price target from $3 to $2.5.
Baird Downgrades Nevro to Neutral, Lowers Price Target to $150
Baird analyst Mike Polark downgrades Nevro (NYSE:NVRO) from Outperform to Neutral and lowers the price target from $188 to $150.
UBS Downgrades Virgin Galactic Hldgs to Neutral, Raises Price Target to $45
UBS analyst Myles Walton downgrades Virgin Galactic Hldgs (NYSE:SPCE) from Buy to Neutral and raises the price target from $36 to $45.
Bernstein Downgrades Reckitt Benckiser Group to Underperform
Bernstein analyst Bruno Monteyne downgrades Reckitt Benckiser Group (OTC:RBGLY) from Market Perform to Underperform.
Credit Suisse Downgrades 3M to Neutral, Raises Price Target to $212
Credit Suisse analyst John Walsh downgrades 3M (NYSE:MMM) from Outperform to Neutral and raises the price target from $210 to $212.
Jefferies Downgrades Atotech to Hold, Lowers Price Target to $26
Jefferies analyst Laurence Alexander downgrades Atotech (NYSE:ATC) from Buy to Hold and lowers the price target from $30.5 to $26.
Jefferies Downgrades British Land Co to Hold
Jefferies analyst Michael Prew downgrades British Land Co (OTC:BTLCY) from Buy to Hold.
Jefferies Downgrades Land Secs Gr to Hold
Jefferies analyst Michael Prew downgrades Land Secs Gr (OTC:LDSCY) from Buy to Hold.
BMO Capital Downgrades Santander Consumer USA to Market Perform, Announces $46 Price Target
BMO Capital analyst James Fotheringham downgrades Santander Consumer USA (NYSE:SC) from Outperform to Market Perform and announces $46 price target.